Yılmaz, M. Et Al. 2012. Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis. Osteoporosis International , vol.23, no.7 , 2059-2062.

Yılmaz, M., Tanınmıs, H., Kara, E., Ozagarı, A., & Unsal, A., (2012). Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis. Osteoporosis International , vol.23, no.7, 2059-2062.

Yılmaz, M. Et Al. "Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis," Osteoporosis International , vol.23, no.7, 2059-2062, 2012

Yılmaz, M. Et Al. "Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis." Osteoporosis International , vol.23, no.7, pp.2059-2062, 2012

Yılmaz, M. Et Al. (2012) . "Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis." Osteoporosis International , vol.23, no.7, pp.2059-2062.

@article{article, author={M. Yılmaz Et Al. }, title={Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis}, journal={Osteoporosis International}, year=2012, pages={2059-2062} }